These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dynamic contrast-enhanced MRI versus Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716 [TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
5. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes. Vidiri A; Gangemi E; Ruberto E; Pasqualoni R; Sciuto R; Sanguineti G; Farneti A; Benevolo M; Rollo F; Sperati F; Spasiano F; Pellini R; Marzi S PLoS One; 2020; 15(3):e0229611. PubMed ID: 32119697 [TBL] [Abstract][Full Text] [Related]
6. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors. An YS; Kang DK; Jung YS; Han S; Kim TH Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT. Zhang J; Chen Y; Zhang Y; Zhang E; Yu HJ; Yuan H; Zhang Y; Su MY; Lang N Eur Spine J; 2020 May; 29(5):1061-1070. PubMed ID: 31754820 [TBL] [Abstract][Full Text] [Related]
8. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and Tang L; Wang XJ; Baba H; Giganti F Eur Radiol; 2020 Jan; 30(1):247-260. PubMed ID: 31392480 [TBL] [Abstract][Full Text] [Related]
9. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model. Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial. Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography. Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080 [TBL] [Abstract][Full Text] [Related]
13. The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute. Han M; Kim SY; Lee SJ; Choi JW Medicine (Baltimore); 2015 Nov; 94(47):e2141. PubMed ID: 26632740 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449 [TBL] [Abstract][Full Text] [Related]
15. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994 [TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer. Du Y; Zhang S; Liang T; Shang J; Guo C; Lian J; Gong H; Yang J; Niu G Acta Radiol; 2023 Feb; 64(2):572-580. PubMed ID: 35369721 [TBL] [Abstract][Full Text] [Related]
17. The impact of Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508 [TBL] [Abstract][Full Text] [Related]
18. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
19. Multiparametric functional MRI and Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors. Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]